Clene Inc
NASDAQ:CLNN 3:59:53 PM EDT
| Market Cap (Intraday) | 313.20M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $5.14 |
| 50-Day MA | $5.76 |
| 200-Day MA | $9.15 |
Clene Inc Stock, NASDAQ:CLNN
6550 South Millrock Drive, Suite G50, Salt Lake City, Utah 84121
United States of America
Phone: +1.801.676.9695
Number of Employees:
Description
Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutics for neurodegenerative diseases. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded on August 12, 2020 and is headquartered in Salt Lake City, UT.